Beyond Air Overview
- Year Founded
-
2011
- Status
-
Public
- Employees
-
107
- Stock Symbol
-
XAIR
- Investments
-
2
- Share Price
-
$0.20
- (As of Wednesday Closing)
Beyond Air General Information
Description
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
Contact Information
Website
www.beyondair.netCorporate Office
- 900 Stewart Avenue
- Suite 301
- Garden City, NY 11530
- United States
Corporate Office
- 900 Stewart Avenue
- Suite 301
- Garden City, NY 11530
- United States
Beyond Air Timeline
Beyond Air Stock Performance
As of 18-Jun-2025, Beyond Air’s stock price is $0.20. Its current market cap is $17.5M with 86.4M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.20 | $0.28 | $0.16 - $1.49 | $17.5M | 86.4M | 2.68M | -$0.69 |
Beyond Air Financials Summary
As of 31-Mar-2025, Beyond Air has a trailing 12-month revenue of $3.71M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 |
|---|---|---|---|---|
| EV | 15,852 | 15,852 | 68,191 | 157,322 |
| Revenue | 3,705 | 3,705 | 1,159 | 0 |
| EBITDA | (59,031) | (58,201) | ||
| Net Income | (46,625) | (46,625) | (60,242) | (55,816) |
| Total Assets | 30,062 | 30,062 | 56,961 | 68,749 |
| Total Debt | 11,688 | 11,688 | 17,837 | 3,592 |
Beyond Air Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Beyond Air Comparisons
Industry
Financing
Details
Beyond Air Competitors (8)
One of Beyond Air’s 8 competitors is Savara, a Formerly VC-backed company based in Langhorne, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Savara | Formerly VC-backed | Langhorne, PA | ||||
| VERO Biotech | Private Equity-Backed | Atlanta, GA | ||||
| Bedfont | Corporation | Maidstone, United Kingdom | ||||
| Respira Therapeutics | Venture Capital-Backed | Palo Alto, CA | ||||
| Pulmatrix | Formerly VC-backed | Framingham, MA |
Beyond Air Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Beyond Air Patents
Beyond Air Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023302931-A1 | Cancer treatment using ultra-high concentration gaseous nitric oxide and a checkpoint inhibitor | Pending | 06-Jul-2022 | ||
| EP-4551233-A1 | Cancer treatment using ultra-high concentration gaseous nitric oxide and a checkpoint inhibitor | Pending | 06-Jul-2022 | ||
| AU-2023231103-A1 | Methods of selecting treatment for cancer | Pending | 07-Mar-2022 | ||
| EP-4489764-A1 | Methods of selecting treatment for cancer | Pending | 07-Mar-2022 | ||
| AU-2022282869-A1 | Methods of producing tumor vaccines and uses thereof | Pending | 26-May-2021 | A61K40/10 |
Beyond Air Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Beyond Air Acquisitions (2)
Beyond Air’s most recent deal was a Merger/Acquisition with KokiCare. The deal was made on 13-Jan-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| KokiCare | 13-Jan-2017 | Merger/Acquisition | Social/Platform Software | ||
| CSM (Saint-Maximin Factory) | 17-Jul-2008 | Merger/Acquisition | Food Products |
Beyond Air ESG
Risk Overview
Risk Rating
Updated April, 26, 2025
29.32 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,673
Rank
Percentile
Software & Services
Industry
of 941
Rank
Percentile
Enterprise and Infrastructure Software
Subindustry
of 375
Rank
Percentile
Beyond Air FAQs
-
When was Beyond Air founded?
Beyond Air was founded in 2011.
-
Where is Beyond Air headquartered?
Beyond Air is headquartered in Garden City, NY.
-
What is the size of Beyond Air?
Beyond Air has 107 total employees.
-
What industry is Beyond Air in?
Beyond Air’s primary industry is Therapeutic Devices.
-
Is Beyond Air a private or public company?
Beyond Air is a Public company.
-
What is Beyond Air’s stock symbol?
The ticker symbol for Beyond Air is XAIR.
-
What is the current stock price of Beyond Air?
As of 18-Jun-2025 the stock price of Beyond Air is $0.20.
-
What is the current market cap of Beyond Air?
The current market capitalization of Beyond Air is $17.5M.
-
What is Beyond Air’s current revenue?
The trailing twelve month revenue for Beyond Air is $3.71M.
-
Who are Beyond Air’s competitors?
Savara, VERO Biotech, Bedfont, Respira Therapeutics, and Pulmatrix are some of the 8 competitors of Beyond Air.
-
What is Beyond Air’s annual earnings per share (EPS)?
Beyond Air’s EPS for 12 months was -$0.69.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
